ACELRX PHARMACEUTICALS INC (50) | Intellectual Property (2)
- License Agreements (2 contracts)
- License and Commercialization Agreement (DZUVEO), dated July 14, 2021, between Laboratoire Aguettant and the Registrant (Filed With SEC on November 15, 2021)
- License and Commercialization Agreement (PFS), dated July 14, 2021, between Laboratoire Aguettant and the Registrant (Filed With SEC on November 15, 2021)